InvestorsHub Logo
Followers 4
Posts 133
Boards Moderated 0
Alias Born 09/26/2018

Re: Sam81 post# 194110

Thursday, 05/30/2019 8:24:25 AM

Thursday, May 30, 2019 8:24:25 AM

Post# of 426389
Thanks Sam. IMHO Evaporate is a huge potential catalyst that the Street has essentially ignored. Patient's can easily visualize the concept of a 'liquid stent" (think Drano for your coronary arteries). The data is purely objective and irrefutable. I agree that every CV patient that is a potential candidate for surgical intervention (stent or bypass) or has historically undergone these procedures will be put on Vascepa based on this study. Cherry was done with a much lower dose and its results were still very robust.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News